Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
MOORESTOWN, N.J., Aug. 29, 2017 -- Tabula Rasa HealthCare Corporation (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, announces that the largest Program of All-Inclusive Care for the Elderly organization (PACE) has signed an agreement for medication risk management services with CareKinesis, its wholly owned subsidiary focused on PACE. CenterLight Healthcare PACE selected TRHC to work with the Interdisciplinary Care Team (IDT) to streamline workflows and improve outcomes for participants. The agreement will begin with a launch center with additional locations to be added over time in consideration of specific clinical, economic, and satisfaction-related outcomes.
CenterLight Healthcare’s PACE Organization is a vanguard of the community physician model that enables patients to keep their primary care physician once they enroll in PACE. This model is now enabled through a waiver program. CMS is considering eliminating the waiver in its newly proposed conditions of participation to increase access to PACE. TRHC will collaborate with CenterLight network and employed prescribers and staff to reduce hospital admissions, re-admissions and total costs while increasing participant and provider satisfaction.
“We have been exploring options for a medication risk partner,” said CenterLight Chief Medical Officer, Dr. Thomas. “It has been a pleasure to learn about Tabula Rasa’s unique Medication Risk Mitigation® software and Medication Decision Support and Adherence tools that personalize each participant’s medication regimen. We look forward to improving quality and outcomes for our PACE participants.”
“TRHC continues to advance the practice and science of medication risk mitigation through our personalized medicine approach,” said Chairman and CEO Calvin H. Knowlton, PhD. “We are pleased to have formalized this collaboration with CenterLight with the goal of optimizing outcomes for their participants by reducing the risk of adverse drug events while improving adherence.”
The Agreement takes effect September 1, 2017.
About CenterLight Healthcare PACE
CenterLight Healthcare is an innovative managed care organizations that excels in providing long-term healthcare services throughout the Bronx, Kings (Brooklyn), New York (Manhattan), Queens, Richmond (Staten Island), Nassau, Suffolk and Westchester counties. CenterLight’s goal is to help clients enjoy the highest possible quality of life while living safely in their own homes and communities.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Since 2011, TRHC, through its wholly-owned subsidiary, CareKinesis, has focused on optimizing outcomes for PACE and other healthcare organizations using its unique Medication Risk Mitigation software and Medication Decision Support and Adherence tools that personalize each participants medication regimen. For more information, please visit: www.TRHC.com.
Contact: Media TRHC Dianne Semingson [email protected] T: 215-870-0829
